As the World Health Organisation announced the resumption of the antimalarial drug hydroxychloroquine in the solidarity trail for the treatment of COVID 19 disease, experts across the country hailed the decision by the world health body in one voice.
Speaking to , Director General of the Council of Scientific and Industrial Research, Dr Shekhar C. Mande said the decision is welcome. "I am pleased to note that the WHO has resumed the trial of hydroxychloroquine again. The Lancet paper based on which the trial was temporarily suspended, was not on sound ground. Therefore WHO's decision is welcome. I firmly believe that the WHO's decision was taken in haste. It was a kind of kneejerk reaction. They should have analysed the data on their own before temporarily suspending trials."
Similarly Dr Arvind Kumar, founder trustee of the Lung Care Foundation told that it was shocking to learn about the suspension of the hydroxychloroquine
( With inputs from IANS )